EISAI CORPORATION OF NORTH AMERICA
(847) 832-0469
100 Tice Blvd
Woodcliff Lake, New Jersey,
USA
07677-8404
information about eisai pharmaceuticals prescription drugs aricept, cerebyx, zonegran, fragmin and aciphex used for treatment of alzheimer's disease and neurology disorders, peptic ulcers, gerd and nighttime heartburn, status epilepticus, epilepsy and prevention of deep-vein thrombosis (dvt).
- Annual Sales
- US$5 Million - US$10 Million
Products & Services
-
- "eisai
- Aricept
- Alzheimer's
- Neurology
- Aciphex Gerd
- Cerebyx
- Status Epilepticus
- Zonegran Epilepsy
-
- Fragmin Deep-vein Thrombois
- Oncology
- Cancer Treatment
- Gastrointestinal Disease
- Acute Care
- Caregiving
- Human Health Care
Web Result
- AcipHex
- Eisai Glossary AcipHex Eisai product names A proton-pump inhibitor(*) marketed by Eisai. Effective in the treatment of gastric and duodenal ulcers and gastroesophageal reflux disease (GERD). Generic name: rabeprazole sodium. It is marketed under the name of AcipHex in the U.S., and is known as Pariet in Japan and Europe. It is one of Eisai's leading global products. (*)Proton pump inhibitor (PP...
- Pariet
- Eisai Glossary Pariet Eisai product names A proton-pump inhibitor(*) marketed by Eisai. Effective in the treatment of gastric and duodenal ulcers and gastroesophageal reflux disease (GERD). Generic name: rabeprazole sodium. It is marketed under the name of AcipHex in the U.S., and is known as Pariet in Japan and Europe. It is one of Eisai's leading global products. (*)Proton pump inhibitor (PPI...
- What Kinds of Drugs are...
- Message from President Corporate Information Access to Medicines Corporate Governance Japan Business Sites Production and Logistics Marketing News Releases Corporate Philosophy What is hhc? Compliance Message to Stakeholders Eisai's Views on Environmental Issues Environmental and Social Report Social Contribution Activities Potential Suppliers Business Performance Highlights Financial Information ...
- What are the Other Aspects...
- Proton pump inhibitor (PPI)
- Eisai Glossary Proton pump inhibitor (PPI) Pharmaceuticals/treatments A drug used in the treatment of gastric and duodenal ulcers and gastroesophageal reflux disease (GERD). The drug suppresses the secretion of gastric acid by blocking the activation of the proton pump, which is the final stage in the process of gastric acid secretion from the cells of the stomach mucosal wall. ...
Website Links:
Eisai, Inc. | 1 Minute Guide to 4 Key Points | 1. Understanding Products | 2. Understanding Strengths | 3. Understanding Research... | 4. Understanding Business... | AbbVie and Eisai Announce... | Access to Medicines | Access to Medicines Eisai... | Acetylcholin-esterase... | AcipHex | Analyst Coverage | Annual Report | Aricept | Bonds and Ratings | Business Performance... | Commitment & Passion... | Compliance | Corporate Governance... | Corporate Information
Own this business?
Request to update the information